With new data, Pliant drug shows promise in tough-to-treat lung disease

An experimental medicine from Pliant Therapeutics improved a measure of lung function in a small, short clinical trial of idiopathic fibrosis patients, a tough-to-treat disease that’s proved a challenging target for drugmakers.